Skip to main content
OpenTrials

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,050 public trials 570 recruiting studies
Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Completed

A Study of Daratumumab With the Addition of Recombinant Human Hyaluronidase (rHuPH20) for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma

NCT02519452

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Atlanta, Georgia, United States
  • New York, United States
  • Charlotte, North Carolina, United States
  • Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma

NCT03361748

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Local Institution - 108 San Francisco, California, United States
  • University of California - San Francisco San Francisco, California, United States
  • Emory University Atlanta, Georgia, United States
  • Local Institution - 103 Atlanta, Georgia, United States
View all 48 locations
View Trial Details
Completed

Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.

NCT03158688

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Lynn Cancer Center Boca Raton Regional Hospital, Lynn Cancer Institute Boca Raton, Florida, United States
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • University of Chicago Medical Center - Multiple Myeloma Research Consortium Chicago, Illinois, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
View all 113 locations
View Trial Details
Completed

A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

NCT02076009

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Little Rock, Arkansas, United States
  • Gainesville, Florida, United States
  • West Palm Beach, Florida, United States
  • Atlanta, Georgia, United States
View all 145 locations
View Trial Details

Related conditions